21
Registered Charity Number 207890 Accepted Manuscript This is an Accepted Manuscript, which has been through the RSC Publishing peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, which is prior to technical editing, formatting and proof reading. This free service from RSC Publishing allows authors to make their results available to the community, in citable form, before publication of the edited article. This Accepted Manuscript will be replaced by the edited and formatted Advance Article as soon as this is available. To cite this manuscript please use its permanent Digital Object Identifier (DOI®), which is identical for all formats of publication. More information about Accepted Manuscripts can be found in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics contained in the manuscript submitted by the author(s) which may alter content, and that the standard Terms & Conditions and the ethical guidelines that apply to the journal are still applicable. In no event shall the RSC be held responsible for any errors or omissions in these Accepted Manuscript manuscripts or any consequences arising from the use of any information contained in them. www.rsc.org/advances RSC Advances View Article Online View Journal

Recent progress in the field of multicomponent bioactive nanostructured films

  • Upload
    igor-v

  • View
    215

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Recent progress in the field of multicomponent bioactive nanostructured films

Registered Charity Number 207890

Accepted Manuscript

This is an Accepted Manuscript, which has been through the RSC Publishing peer review process and has been accepted for publication.

Accepted Manuscripts are published online shortly after acceptance, which is prior to technical editing, formatting and proof reading. This free service from RSC Publishing allows authors to make their results available to the community, in citable form, before publication of the edited article. This Accepted Manuscript will be replaced by the edited and formatted Advance Article as soon as this is available.

To cite this manuscript please use its permanent Digital Object Identifier (DOI®), which is identical for all formats of publication.

More information about Accepted Manuscripts can be found in the Information for Authors.

Please note that technical editing may introduce minor changes to the text and/or graphics contained in the manuscript submitted by the author(s) which may alter content, and that the standard Terms & Conditions and the ethical guidelines that apply to the journal are still applicable. In no event shall the RSC be held responsible for any errors or omissions in these Accepted Manuscript manuscripts or any consequences arising from the use of any information contained in them.

www.rsc.org/advances

RSC AdvancesView Article OnlineView Journal

Page 2: Recent progress in the field of multicomponent bioactive nanostructured films

Ti

bone

bone

Polymer

MuBiNaF

Page 1 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 3: Recent progress in the field of multicomponent bioactive nanostructured films

Recent progress in the field of multicomponent bioactive nanostructured films

Dmitry V. Shtanskya, Evgeny A. Levashova, Irina V. Bateninaa, Natalia A. Gloushankovab,

Natalia Y. Anisimovab, Mikhail V. Kiselevskyb, and Igor V. Reshetovc

a National University of Science and Technology “MISIS”, Leninsky prospect 4, Moscow 119049,

Russia b Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences,

Kashirskoe shosse 24, Moscow 115478, Russia c Hertsen Moscow Oncological Research Institute, 2nd Botkinsky driveway 3, Moscow 125284,

Russia

E-mail: [email protected]

Tel.: +7-499-236-6629

Multicomponent bioactive nanostructured films (MuBiNaFs) with an excellent

combination of chemical, mechanical, tribological, and biological properties were

developed and deposited by sputtering of composite targets produced via the self-

propagating high-temperature synthesis method. Reviewed substrate materials included

Ti-, Ni-, and Co-based alloys, insoluble polymers, and deimmunized donor’s bones. Our

results showed that the MuBiNaF deposition can be effectively combined with either a bulk

material modification to improve its mechanical properties, or a surface modification to

control surface roughness and blind porosity. Among other promising applications, the

fabrication of hybrid materials incorporated with stem cells or medicine is mentioned.

1. Present state-of-the-art

Bone and joint degenerative and inflammatory problems affect millions of people

worldwide and the development of patient-friendly biomaterials is a challenge that biological

community has faced for many years. However, the materials of dream were not yet developed.

The main efforts are focused on the design of new biomaterials with accelerated self-adaptation

in human body, which would reduce the patient’s rehabilitation period, and with improved

chemical and mechanical properties, which would markedly increase the implant lifetime. This,

however, is not easy because the sought advanced biomaterials should possess a combination of

properties such as biocompatibility, bioactivity, wettability, corrosion resistance, good

mechanical and tribological properties, which cannot be found in one single material.

Page 2 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 4: Recent progress in the field of multicomponent bioactive nanostructured films

2

Surface engineering is an effective tool to modify surface characteristics of various

materials (e.g. metals and polymers, as those widely used in biomedical applications), while

retaining their bulk properties. Most of the materials currently used in medicine, have certain

drawbacks. For instance, titanium and its alloys have been well known as one of the best choices

for load-bearing implants for many years, which is explained by their high strength combined

with excellent plastic characteristics, high chemical stability, and good biological compatibility.1

At the same time, they demonstrate insufficient wear- and corrosion resistance, high friction

coefficient, and poor bioactivity, thus implying the necessity of surface modification. In addition,

the formation of wear debris and metal ion release may cause loosening of implant fixation and

toxic response, respectively. In turn, insoluble polymers and polytetrafluoroethylene (PTFE) in

particular attracted much attention as nonporous materials and porous scaffolds for load carrying

and supporting implants, fixation devices, bulk space fillers, prostheses, artificial blood vessels,

pericardium and vascular grafts, and heart valves.2 The shortcomings of PTFE include its

hydrophobicity, which prevents the attachment of cells to its surface, and insufficient interfacial

bonding between the polymer surface and the surrounding bone.3

An effective way to improve the surface properties of bulk biomaterials and to promote the

interaction between the implant surface and surrounding tissue is the deposition of

multifunctional bioactive films. Hydroxyapatite (HA), Ca10(PO4)6(OH)2, and calcium phosphate

(CaP) ceramics are widely used as a bioactive interface between the bulk metal implant and the

surrounding tissue because of their close similarity to the chemical and mineral components of

teeth and bones. However, these pure compounds cannot be used as load-bearing components

due to their poor mechanical properties.4 The properties of HA and CaP ceramics can be further

improved by doping with other elements, e.g. Ti,5,6 Si,7,8 and Mg.9 These dopants may

demonstrate a positive affect either on the coating mechanical properties (adhesion strength (Ti)

or viscosity (Mg)) or on material biological characteristics (Si). Another interesting application

of the CaP-based materials is a fabrication of composite coatings consisting of CaP and

biodegradable polymers.10-12 These biodegradable composite materials have some advantages

over pure biodegradable polymers due to the presence of a bioactive substance with pH-

stabilizing effect, which prevents the surrounding tissue damage.11

Plasma-assisted methods for CaP-based coating fabrications were recently reviewed by

Surmenev.13 The review shows that different plasma-assisted methods, e.g. plasma spraying (PS),

radio-frequency (RF) magnetron sputtering, pulsed laser deposition (PLD), and ion beam-

assisted deposition (IBAD), are well suitable for the deposition of dense, homogeneous, pore-

free and highly adherent biocompatible coatings. Plasma immersion ion implantation and

Page 3 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 5: Recent progress in the field of multicomponent bioactive nanostructured films

3

deposition (PIII&D) is another effective technique to enhance the surface bioactivity of

materials.14-16

In the design of new multicomponent bioactive films, particular attention should be paid to

elemental and phase composition, and, in this context, Ti, Ta, Zr, Ca, P, C, N, and O are suitable

elements to optimize surface chemistry and promote fast osseointegration. Using the concept of

nanocomposite materials it is possible to produce films in which some of the phase constituents

provide mechanical strength and wear resistance, while others are bioactive. In this work, our

recent progress and results in the field of multicomponent bioactive nanostructured films

(MuBiNaFs) with an excellent combination of chemical, mechanical, tribological, and biological

properties for load-bearing implants is reviewed.

A new approach to design MuBiNaFs involves two main technological steps: (i)

development and fabrication of composite targets and (ii) film deposition using sputtering of the

composite targets. The capabilities of ion-plasma technology can be substantially extended

through the use of composite targets produced by the self-propagating high-temperature

synthesis (SHS).17 The SHS-technology allows one to produce a wide spectrum of targets based

on ceramics, metal ceramics, and intermetallic compounds.18 SHS is an alternative method to

various powder-metallurgy based approaches (cold pressing, hot extrusion, hot isostatic pressing,

etc.) and provides a highly dense, uniform structure that exhibits required mechanical, thermal,

and electrical properties needed for composite PVD target materials.19 Various multicomponent

films (to date, up to six elements) can be deposited using a single SHS-fabricated composite

target, which allows the use of a simple sputtering unit. During the magnetron sputtering of

composite targets, a multicomponent uniform flow of both metal and nonmetal atoms and ions is

realized from the target to substrate, which is particularly beneficial for the deposition of

MuBiNaFs and in which both metal (Ca, Ti, Ta, Zr) and nonmetal (C, N, O, Si, P) elements are

present.20 During the last decade various SHS-composite targets have been developed and

synthesized for the deposition of MuBiNaFs, such as TiC0.5 + CaO, TiC0.5 + ZrO2, TiC0.5 + CaO

+ TiO2, TiC0.5 + Ca10(PO4)6(OH)2, TiC0.5 + Ca3(PO4)2, (Ti,Ta)C + Ca3(PO4)2, and (Ti,Ta)C +

CaO).21,22 The type and amount of various inorganic additives in the TiC- and (Ti,Ta)C-based

composite targets permitted to control biological characteristics of films without compromising

their mechanical and tribological properties. In order to enhance the toughness and thermal

resistance (resistance to thermal cycling during high-power magnetron sputtering) required for

PVD targets, functionally graded targets have been also developed, manufactured, and used.

The chemical reactions in various systems have been investigated.21,23 Only one chemical

reaction between Ti and C was observed during SHS of TiC-based targets with various inorganic

additives such as (Ti+0.5C)+CaO, (Ti+0.5C)+ZrO2, (Ti+0.5C)+Ca3(PO4)2, and

Page 4 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 6: Recent progress in the field of multicomponent bioactive nanostructured films

4

(Ti+0.5C)+Ca10(PO4)6(OH)2.23 For Ta-doped targets, the synthesis process was more complex

and depended on the charging parameter x: (90% – x)(Ti + 0.5C) + x(Ta + C) + Ca3(PO4)2.21 For

small x, two well resolved combustion waves propagated though the green mixture within a short

interval resulting in the formation of TiC and TaC phases with a short delay relative to each

other. When the charging parameter x was increased to 45% and the initial heating temperature

increased to 420 °C, the chemical reactions proceeded in one step, the combustion rate being the

same. The observed differences in the combustion modes can be explained as follows. At low Ta

concentrations at the combustion front, Ti melts and flows over the surface of C particles. The

formation of TiC occurs either on the surface of ash particles or during the crystallization of Ti-C

melt. In this case, Ta reacts with carbon in the afterburning zone. Such a combustion mode is

usually called the “detached mode”. As the Ta content increases, the intensity of the second

reaction increases, while that of the first reaction between Ti and C substantially decreases, and

the combustion gradually transforms into the coalescence mode.

For MuBiNaFs deposition, different methods were employed. The films were obtained by

magnetron sputtering24-26, ion implantation-assisted magnetron sputtering (IIAMS),27-29 and а

hybrid process involving sputter deposition and either inductively-coupled plasma (ICP)30-32 or

an RF system for an additional ionization.33 IIAMS was used to enhance film adhesion to the

metal substrate via high-energy ion bombardment several minutes before and after the beginning

of deposition. In ionized physical vapor deposition processes using ICP or RF systems, the

sputtered species were highly ionized, which led to highly-dense films. A similar dense

homogeneous structure was also observed when a high bias voltage (-250 V) was applied during

dc magnetron sputtering.27

For the first generation of MuBiNaFs, composite targets TiC0.5+X [X=CaO, ZrO2, TiO2,

Ca3(PO4)2, and HAP(Ca10(PO4)6(OH)2)] were manufactured by means of SHS.24-27 All the films

deposited in a gaseous mixture of Ar+N2 had a nanocomposite structure with cubic B1 NaCl-

type crystallites, with sizes smaller than 20 nm, embedded in an amorphous matrix (Fig. 1). Fig.

2 shows the Ti-L2,3, O-K, C-K, Ca-L2,3, N-K, and P-L2,3 energy-loss near-edge structures of the

TiCaPCON film deposited using the target TiC0.5+Ca3(PO4)2. The Ti-L2,3, N-K, and C-K spectra

exhibited peak shapes and positions similar to those of TiC and TiN. The presence of

characteristic Ca-L2,3, P-L2,3, and O-K edge structures indicates that Ca and P are in oxidized

states, probably in an amorphous matrix. The elemental composition of the TiCaPCON film was

determined from EELS data and is shown in Table 1.

The MuBiNaFs demonstrated a combination of mechanical and tribological properties

superior to those of Ti-, Ni-, and Co-based alloys, which are widely used as orthopedic and

dental implants, as well as to those of their binary TiC and TiN thin film counterparts. The

Page 5 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 7: Recent progress in the field of multicomponent bioactive nanostructured films

5

MuBiNaFs were characterized by high hardness 25-40 GPa combined with a high percentage of

elastic recovery (up to 75%) and reduced Young’s modulus of 230-350 GPa, which are lower

than those of bulk ceramics (TiN – 440 GPa, TiC – 480 GPa, SiC - 450 GPa, Al2O3 - 390 GPa)

and closer to the modulus of stainless steel (200 GPa) and Ti (120 GPa). The benefits of a

moderately low Young’s modulus in implant applications are well known: (i) a better transfer of

functional loads to the bone and (ii) a reduced interfacial stress between the film and substrate

materials. The MuBiNaFs also showed high resistance to plastic deformation (up to 0.9 GPa) and

long elastic strain to failure, which was previously reported as a good indicator of high film

durability and wear resistance.34 Other mechanical characteristics of the films included a high

fatigue limit of 350 MPa (MuBiNaFs on a Grade 4 Ti substrate), high adhesion strength (up to

50 N), and excellent impact resistance. In general, the MuBiNaFs demonstrated a hydrophilic

nature, a negative surface charge at pH 5-8.5, and positive values of corrosion potential with low

current density under various biological solutions. It should be noted that for the Ca- and P-

doped TiCON films the proliferation of MC3T3-E1 osteoblastic cells was visibly higher than on

the surface of control samples.24 In addition, MC3T3-E1 osteoblasts cultivated for 14 days on the

surface of TiCaCON films showed a two-fold higher alkaline phosphatase (ALP) activity than

those on the control sample.

The in vivo investigations included three types of tests using the rat (i) calvarian defect

model, (ii) hip defect model, and (iii) subcutaneous model. Implantation studies indicated early

signs of bone formation on coated titanium implants. After one month, a close contact between

the implant surface and cortical bone was observed without any bone losses at the interface (Fig.

3). The biocompatibility of the MuBiNaFs was also confirmed in biological tests using larger

animals (rabbits and pigs).35

In 2008, clinical studies initiated with metallic implants for cranial-jaw-face surgery, spine

surgery, and hip joints coated with TiCaCON and TiCaPCON films. These types of MuBiNaFs

were evaluated at the P.A. Hertsen Moscow Research Oncological Institute and the Central

Institute of Traumatology and Orthopeadics, Moscow and subsequently were approved for

medical applications on the territory of the Russian Federation.

More recently, we have explored novel advanced approaches to MuBiNaFs by doping the

Ti-Ca-P-C-O-N films with Ta and Si.28,29,36 This second generation of MuBiNaFs was shown to

possess a nanocomposite structure with various functional groups on the film surface that

stimulate accelerated osseointegration. For instance, the Si-doped TiCaCO(N) films sputter-

deposited using composite TiC0.5+CaO+Si and TiC0.5+CaO+Si3N4 targets consisted of TiC(N) as

a main phase with a minor amount of TiOx, SiNx, SiOx, SiC, and CaO phases, which were

probably mainly in an amorphous state at the grain boundaries, and carboxyl groups on the film

Page 6 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 8: Recent progress in the field of multicomponent bioactive nanostructured films

6

surface among others. Excess carbon atoms precipitated in the TiSiCaCON film as amorphous

carbon or diamond-like carbon (DLC) phase. The Si-doped TiCaCON films possessed improved

osteoconductive characteristics during the early stages of cell/material interaction. The ALP

level of MC3T3-E1 cells grown on the Si-doped films was significantly higher than that on an

uncoated coverslip and coverslips coated with Ti and TiN films. The Ta-doped Ti-Ca-(P)-C-O-

(N) films deposited in argon consisted of (Ti,Ta)C, TixOy, and CaO phases in an amorphous

matrix with P-O, C-O, and O-H bonding.29 The films reactively sputtered in an Ar+N2

atmosphere exhibited (Ti,Ta)(C,N), TixOy, and CaO phases, DLC, bcc Ta and trace amounts of

P-O bonding. The Ta-doped films also showed a high rate of osteoblastic cell proliferation and

high level of ALP.

It was also shown that the modification of a PTFE surface by the deposition of TiCaPCON

films with and without adipose-derived stem cells (ASCs) is an effective way to improve the

chemical and mechanical characteristics of polymer implants and provide them with a high

osseointegration potential.37 The TiCaPCON/PTFE samples demonstrated a hardness of 0.6 GPa,

Young’s modulus 4.8 GPa, and percentage of elastic recovery 61%, which are significantly

higher than those of the uncoated PTFE (H=0.04 GPa, E=0.9 GPa, and We=30%). After film

deposition, the water contact angle decreased from 100 to 18o, indicating that the surface became

hydrophilic, which is believed to be favorable for good cell attachment, spreading and

proliferation.38,39 In vivo tests clearly demonstrated that the porous PTFE plates with TiCaPCON

films induced the formation of a mature bone tissue, which filled in all the area of the critical

bone defect of the rabbit’s calvaria. This can be regarded as an indication of a very high

osseoinduction potential of such films. Particular attention was paid to studying the influence of

ion etching and ion implantation, which are widely used in surface treatment to improve film

adhesion, on the cytotoxicity of PTFE.40 It was demonstrated that, unlike the ion implantation,

the ion etching resulted in the destruction of the polymer and appearance of the cytotoxicity.

The interaction between an implant and surrounding tissues is a complex dynamic

process whose efficiency largely depends not only on the implant surface chemistry but also on

the surface topography and roughness. The possibility to produce biocompatible materials with

controllable surface roughness, blind porosity, and desired chemical composition opens new

avenues for the design of novel metal-ceramic implants. Yet the question arises as to whether it

is possible to obtain a synergetic effect by a proper choice of both surface chemistry and

roughness. To address this question, the influence of elemental composition and surface

roughness on the osteoblastic MC3T3-E1 cell behavior was recently investigated.41 Four groups

of Ti samples, as-supplied Ti and sandblast-treated Ti with and without TiCa(P)CON films, were

used in the test. The obtained results show that surface chemistry was important at different

Page 7 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 9: Recent progress in the field of multicomponent bioactive nanostructured films

7

stages of the osteoblast/implant interaction, while surface roughness (root-mean-square

roughness Sq in the range of 0.4-1.0 m) was not observed to have any significant influence on

adhesion, proliferation and differentiation of osteoblasts.41

The investigation revealing the role of surface chemistry and topography, both separate and

in synergy, was extended further to samples with porosity in the range of 100-300 m and

average roughness Ra=1-100 m. To achieve this goal, a new combined approach using cold

spray (CS), selective laser sintering (SLS), pulsed electro-erosion treatment (PEET), and

magnetron sputtering methods was developed to fabricate metal-ceramic materials with

controlled topography, blind porosity, and desired surface chemistry.42 The results indicated that

the change of surface porosity and roughness may influence the adhesion, spreading, growth, and

differentiation of osteogenic cells. It was also shown that the bioactivity of Ti surfaces can be

well controlled by a proper choice of surface chemistry and topography. The ALP level of

MC3T3-E1 cells growing on the PEET-treated sample with Ra=8 m was 1.6 times higher than

that of cells on a flat Ti control. This result implies that the bioactivity of Ti alloys can be well

controlled by a proper choice of surface topography. The deposition of the TiCaPCON coating

resulted in a further increase of ALP activity, but the difference was not significant. Our results

also clearly indicated that the deposition of the TiCaPCON film on the surface of PEET-

modified sample with Ra=3 m improved its bioactivity, whereas surface roughness itself did not

affect the ALP activity (Table 2). Additional studies are needed to reveal the synergetic role of

surface chemistry and topography. The obtained metal-ceramic materials with high surface

roughness and blind porosity were also shown to be suitable as orthopedic implants with

microcontainers for medicine.42

It is worth noting that safety and reliability of the medical systems, especially load-bearing

ones, should be addressed with special attention. The adhesion and deformation characteristics of

MuBiNaFs deposited on different substrates were studied using the scratch test.43 Depending on

the type of substrate material, three cases were treated: (i) hard film on hard substrate, (ii) hard

film on soft substrate with a low value of E/H ratio (mostly elastic contact), and (iii) hard film on

soft substrate with a high value of E/H ratio (mostly plastic deformation). It was shown that

critical loads responsible for different types of adhesion and cohesion failure of the films could

be determined from a set of parameters recorded during their scratching.

2. Undergoing scientific research

A key MuBiNaFs property that can be improved further is their antibacterial effect.

Implant-related microbial infections remain a serious problem in orthopedic and dental surgery.

Page 8 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 10: Recent progress in the field of multicomponent bioactive nanostructured films

8

One of effective ways to overcome this problem is a deposition of an antibacterial film which

minimizes the risk of bacterial contamination without compromising the implant bioactivity and

biocompatibility. Ag-doped TiCaPCON films, which are thereafter referred as third generation

of MuBiNaFs, were tested against Saccharomyces cerevisiae yeast and gram-positive

Lactobacillus acidophilus bacteria and the obtained results are summarized in Table 3. Our

preliminary data showed that doping of TiCaPCON films with 1.2 at.% of Ag resulted in a

decrease of the number of L. acidophilus colonies by 71% after 2 days of incubation and the

bacteriostatic effect reached 100% after 4 days. The absolute concentration of the L. acidophilus

was also decreased. The biocompatibility of the Ag-doped films was evaluated in vitro using

МС3Т3-E1 osteoblastic cells (the results being presented in Table 3). It can be seen that cultured

МС3Т3-E1 cells were well spread on the both tested surfaces (film and control). The МС3Т3-E1

cells cultured on the Ag-doped surface exhibited, however, a reduced level of ALP activity.

Additional studies are in progress to elucidate the observed phenomena in more detail. Note that

recent studies by Greulich et al.44 showed that the toxic effect of silver occurs in a similar

concentration range for both bacteria and human cells, raising doubts about the widespread use

of silver as an antibacterial agent in medical applications.

Nanostructured (nc) titanium alloys exhibit unique characteristics compared with

commercially pure titanium (cp-Ti). The mechanical properties of metals and alloys can be

drastically improved upon a decrease in their mean grain size down to 100 nm by using the

methods of severe plastic deformation.45 The properties of nc-Ti can be further improved by the

deposition of MuBiNaFs. An important issue is, however, that film/substrate fatigue and creep

properties can be different for micro- and nanocrystalline metallic substrates. The impact test is

commonly used to characterize film contact fatigue under repetitive dynamic loading.46 Figure 4

compares diagrams of the impact force vs. the number of impacts leading to the TiCaPCON film

failure on two different substrates, i.e. cp-Ti and nc-Ti. It can be seen that the fatigue limit for

the TiCaPCON/nc-Ti system was drastically increased compared with that on the cp-Ti substrate.

The last, but not least, exciting application of the above discussed films is the fabrication of

bioengineered constructions based on the deimmunized donor’s bone coated with MuBiNaFs and

further colonized by recipient’s mesenchymal stromal cells (Fig. 5). According to our

preliminary results, this complex hybrid structure provides a configuration, which, on one hand,

is anatomically adequate to the original bone, and, on the other hand, promotes both accelerated

tissue fixation and revascularization of the implant (Fig. 6). These two effects are achieved by

the deposition of MuBiNaFs on the bone surfaces. The film was shown to promote cellular

adhesion, cultivation, and proliferation. This approach provides the delivery of a large number of

Page 9 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 11: Recent progress in the field of multicomponent bioactive nanostructured films

9

mesenchymal stromal cells to the implantation zone. Such cells are capable of differentiating to

certain connective tissue cells including, e.g., endotheliocytes.

Conclusions

Recent progress in the field of multicomponent bioactive nanostructured films (MuBiNaFs)

is briefly reviewed in the article. The films were obtained by sputtering of specially designed and

fabricated SHS composite targets on different metal, polymer, and deimmunized donor’s bone

substrates. An excellent combination of properties makes such MuBiNaFs very attractive

materials for bioengineering and modification of metal and polymer surfaces, as well as

deimmunized donor’s bones:

- Nanocomposite structure with various functional surface groups

- High hardness in the range of 25-40 GPa; lower hardness 15-20 GPa for Ag-doped films

- Reduced Young’s modulus in the range of 230-350 GPa

- High resistance to plastic deformation and long elastic strain to failure

- High fatigue limit about 350 MPa

- High adhesion strength up to 50 N

- High percentage of elastic recovery up to 75%

- Low coefficient of friction 0.12-0.22 in normal saline

- Low wear rate 10-6 - 10-7 mm3N-1m-1

- Negative surface charge at pH of 7

- Positive values of corrosion potential with low current density values in biological solutions

- Good wettability (hydrophilicity)

- Bioactivity

- Biocompatibility

- Antibacterial activity.

To get even better synergetic effect of implant modifications, the MuBiNaFs deposition

can be combined with either a bulk material modification, for instance by a severe plastic

deformation to improve mechanical properties, or a surface modification to control surface

roughness and blind porosity. Another promising application is the fabrication of hybrid

materials incorporated with stem cells or medicine.

Acknowledgements

The authors acknowledge the funding from the Ministry of Science and Education of the

Page 10 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 12: Recent progress in the field of multicomponent bioactive nanostructured films

10

Russian Federation during the course of this work. In vivo tests have been conducted with the

ethical approval by the Animal Care and Use Committees of the Blokhin Russian Cancer

Research Center of RAMS and the Hertsen Moscow Oncological Research Institute. We thank

Dr. C. Rojas (ICMS, Seville, Spain) for help with EELS studies and K.A. Kuptsov (MISIS,

Moscow, Russia) for assistance with impact tests.

References

1. D.M. Brunette, P. Tengvall, M. Textor and P. Thomsen, Titanium in Medicine, Springer,

Berlin, (2001).

2. S. Ramakrishna, J. Mayer, E. Wintermantel, K.W. Leong, Compos. Sci. Technol. 2001, 61,

1189-1224.

3. L.L. Hench and J. Wilson, Science, 1984, 226, 630-636.

4. J. Long, L. Sim, S. Xu, K. Ostrikov, Chem. Vap. Deposition, 2007, 13, 299-306.

5. S. Xu, J. Long, L. Sim, C.H. Diong, K. Ostrikov, Plasma Process. Polym. 2005, 2, 373-390.

6. J.D. Long, S. Xu, J.W. Cai, N. Jiang, J.H. Lu, K.N. Ostrikov, C.H. Diong, Mater. Sci. Eng.,

202, C20 175–180.

7. M. A. Surmeneva, R. A. Surmenev, V. F. Pichugin, S. S. Chernousova, and M. Epple, J.

Surf. Invest., 2011, 5, 1202–1207.

8. V. F. Pichugin, M. A. Surmeneva, R. A. Surmenev, I. A. Khlusov, and M. Epple, J. Surf.

Invest., 2011, 5, 863–869.

9. Z. Zyman, M. Tkachenko, M. Epple, M. Polyakov, M. Naboka, Materialwiss.

Werkstofftech. 2006, 37, 474-477.

10. L.J. Chen, M. Wang, Biomaterials, 2002, 23, 2631-2639.

11. W. Linhart, W. Lehmann, M. Siedler, F. Peters, A.F. Schilling, K. Schwarz, M. Amling,

J.M. Rueger, M. Epple, J. Mater. Sci., 2006, 41, 4806-4813.

12. C. Schiller, M. Epple, Biomaterials, 2003, 24, 2037-2043.

13. R.A. Surmenev, Surf. Coat. Technol., 2012, 206, 2035-2056.

14. P.K. Chu, Surf. Coat. Technol., 2007, 201, 8076-8082.

15. P.K. Chu, Surf. Coat. Technol., 2007, 201, 5601-5606.

16. P.K. Chu, Surf. Coat. Technol., 2010, 204, 2853-2863.

17. E.A. Levashov, A.G. Merzhanov and D.V. Shtansky, Advanced technologies, materials and

coatings developed in scientific-educational center of SHS, Galvanotechnik, 2009, 9, 2102-

2114.

Page 11 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 13: Recent progress in the field of multicomponent bioactive nanostructured films

11

18. E.A. Levashov, Y.S. Pogozhev and V.V. Kurbatkina, Advanced ceramic target materials

produced by self-propagating high-temperature synthesis for deposition of functional

nanostructured coatings, Parts 1 and 2, in book: Advances in ceramics – synthesis and

characterization, processing and specific application, edited by Costas Sikalidis, INTECH,

ISBN 978-953-307-505-1, 2011, 3-48.

19. E.A. Levashov, A.S. Rogachev, V.I. Ukhvid and I.P. Borovinskaya, Physico-chemical and

technological bases of self-propagating high-temperature synthesis, Moscow: Binom, 1999,

134-47 (in Russian).

20. E.A. Levashov and D.V. Shtansky, Rus. Chem. Rev., 2007, 76, 463-470.

21. E.A. Levashov, V.V. Kurbatkina, A.S. Rogachev, N.A. Kochetov, E.I. Patsera and N.V.

Sachkova, Rus. J. Non-Ferrous Met., 2008, 49, 404–413.

22. E.A. Levashov, A.S. Rogachev, V.V. Kurbatkina, Y.K. Epishko and N.A. Kochetov, Int. J.

SHS, 2007, 16, 218–24.

23. E.A. Levashov, V.V. Kurbatkina, E.I. Patsera, Yu. S. Pogozhev, S.I. Rupasov and A.S.

Rogachev, Rus. J. Non-Ferrous Met., 2010, 51, 403-433.

24. D.V. Shtansky, N.A. Gloushankova, I.A. Bashkova, M.A. Kharitonova, T.G. Moizhess,

A.N. Sheveiko, F.V. Kiryukhantsev-Korneev, M.I. Petrzhik and E.A. Levashov,

Biomaterials, 2006, 27, 3519-3531.

25. D.V. Shtansky, N.A. Glushankova, A.N. Sheveiko, M.A. Kharitonova, T.G. Moizhess, E.A.

Levashov and F. Rossi, Biomaterials, 2005, 26, 2909-2924.

26. D.V. Shtansky, E.A. Levashov, N.A. Glushankova, N.B. D’yakonova, S.A. Kulinich, M.I.

Petrzhik, F.V. Kiryukhantsev-Korneev and F. Rossi, Surf. Coat. Technol., 2004, 182, 101-

111.

27. D.V. Shtansky, N.A. Gloushankova, I.A. Bashkova, M.I. Petrzhik, A.N. Sheveiko, F.V

Kiryukhantsev-Korneev, I.V. Reshetov, A.S. Grigoryan and E.A. Levashov, Surf. Coat.

Technol., 2006, 201, 4111-4118.

28. D.V. Shtansky, N.A. Gloushankova, A.N. Sheveiko, Ph.V. Kiryukhantsev-Korneev, I.A.

Bashkova, B.N. Mavrin, S.G. Ignatov, S.Yu. Filipopovich and C.Rojas, Surf. Coat.

Technol., 2010, 205, 728-739.

29. D.V. Shtansky, N.A. Gloushankova, I.A. Bashkova, M.A. Kharitonova, T.G. Moizhess,

A.N. Sheveiko, F.V. Kiryukhantsev-Korneev, A. Osaka, B.N. Mavrin, E.A. Levashov, Surf.

Coat. Technol., 2008, 202, 3615-3624.

30. W. Kulisch, P. Colpo, P.N. Gibson, G. Ceccone, D.V. Shtansky, E.A. Levashov, M. Jelinek,

P.J.M. Philip and F. Rossi, Appl. Phys. A, 2006, A82, 503-507.

Page 12 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 14: Recent progress in the field of multicomponent bioactive nanostructured films

12

31. W. Kulisch, P. Colpo, P.N. Gibson, G. Ceccone, D.V. Shtansky , E.A. Levashov and F.

Rossi, Surf. Coat. Technol., 2004, 188-189, 735-740.

32. W. Kulisch, P. Colpo, F. Rossi, D.V. Shtansky and E.A. Levashov, Surf. Coat. Technol.,

2004, 188-189, 714-720.

33. J.C. Imbert, L. de Poucques, C. Boisse-Laporte, J. Bretagne, M.C. Hugon, L. Teule-Gay,

M. Touzeau, D. Shtansky and O. Voldoire, Surf. Coat. Technol., 2005, 200, 717-720.

34. A. Leyland and A. Matthews, Wear 2000, 246, 1-11.

35. I.V. Reshetov, D.V. Shtansky, E.A. Levashov, M.M. Filyushin, V.N. Vasilyev and S.S.

Sukharev, Annals of Plastic, Reconstructive and Aesthetic Surgery, 2010, 3, 63-71 (in

Russian).

36. D.V. Shtansky, I.A. Bashkova, Ph.V. Kiryukhantsev-Korneev, A.N. Sheveiko, E.A.

Levashov, J. Moore and N.A. Gloushankova, Dokl. Biochem. Biophys., 2008, 418 8-10.

37. D.V. Shtansky, A.S. Grigoryan, A.K. Toporkova, A.N. Sheveiko and Ph.V. Kiruykhantsev-

Korneev, Surf. Coat. Technol., 2012, 206, 1188-1195.

38. A. Georgi, F. Grinnel and T. Groth, J. Biomed. Mater. Res., 1996, 30, 385-391.

39. K. Webb, V. Hlady and P.A. Tresco, J. Biomed. Mater. Res., 1998, 41, 422-430.

40. D. V. Shtansky, N. A. Glushankova, F. V. Kiryukhantsev-Korneev, A. N. Sheveiko, and A.

A. Sigarev, Phys. Solid State, 2011, 53, 638–642.

41. D.V. Shtansky, I.Yu. Zhitnyak, I.A. Bashkova, Yu.S. Pogojev, A.N. Sheveyko and N.A.

Gloushankova, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology,

2010, 4, 272-276.

42. D.V. Shtansky, I.V. Batenina, I.A. Yadroitcev, N.S. Ryashin, F.V. Kiryukhantsev-Korneev,

A.E. Kudryashov, A.N. Sheveyko, I.Y. Zhitnyak, N.A. Gloushankova, I.Y. Smurov and

E.A. Levashov, Surf. Coat. Technol., 2012, 208, 14-23.

43. D.V. Shtansky, M.I. Petrzhik, I.A. Bashkova, F.V. Kiryukhantsev-Korneev, A.N. Sheveiko

and E.A. Levashov, Phys. Solid State, 2006, 48, 1301-1308.

44. C. Greulich, D. Braun, A. Peetsch, J. Diendorf, B. Siebers, M. Epple, M. Köller, RSC Adv.,

2012, 2, 6981-6987.

45. R.Z. Valiev, R.K. Islamgaliev and I.V. Alexandrov, Progr. Mater. Sci., 2000, 45, 103-189.

46. K.-D. Bouzakis and A. Siganos, Surf. Coat. Technol., 2004, 185, 150-159.

Page 13 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 15: Recent progress in the field of multicomponent bioactive nanostructured films

13

(a) (b)

Fig. 1 (a) TEM and (b) high-resolution TEM micrographs (cross-section) of the TiCaPCON film

obtained by magnetron sputtering of a TiC0.5 + Ca3(PO4)2 target.

.

Si 5 nm

Page 14 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 16: Recent progress in the field of multicomponent bioactive nanostructured films

14

Fig. 2 EELS spectra of the TiCaPCON film deposited using a TiC0.5+Ca3(PO4)2 target.

O-K

Inte

nsity

, a.u

.

450 500 550 600 Energy loss, eV

Inte

nsity

, a.u

.

300 350 400 450 Energy loss, eV

Inte

nsity

, a.u

.

150 200 250 300 Energy loss, eV

Page 15 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 17: Recent progress in the field of multicomponent bioactive nanostructured films

15

Fig. 3 SEM image of interface between bone and TiCaPCON coated cylindrical Ti rod implanted

in the artificial hip defect of rat for 30 days showing that the surrounding bone comes into close

contact with the implant surface.

Ti

bone

0.02 mm

Page 16 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 18: Recent progress in the field of multicomponent bioactive nanostructured films

16

(a) (b)

Fig. 4 Fatigue limit for TiCaPCON/substrate systems. (a) – cp-Ti and (b) – nc-Ti substrates.

104 5104 105 Number of cycles

104 5104 105 Number of cycles

Impa

ct fo

rce,

N

Impa

ct fo

rce,

N

Page 17 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 19: Recent progress in the field of multicomponent bioactive nanostructured films

17

Fig. 5 TiCaPCON coating colonized with dog’s mesenchymal stromal cells. Light microscopy,

×400.

Page 18 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 20: Recent progress in the field of multicomponent bioactive nanostructured films

18

Fig. 6 Deimmunized dog’s bone coated with a TiCaPCON film after implantation for 3 months:

a) recipient’s tissue; b) the deimmunized donor’s bone coated with a TiCaPCON film.

Hematoxylin and Eosin staining, light microscopy, ×1000.

a b

Page 19 of 20 RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online

Page 21: Recent progress in the field of multicomponent bioactive nanostructured films

19

Table 1

Film elemental composition as determined by EELS.

Elemental composition, at.% Ti C N Ca P O 39.6 37.4 13.0 1.0 0.5 8.5

Table 2

ALP activity in MC3T3-E1 cells.

Sample Ra, m ALP activity (nmol/mg protein/min)

control (F12) 62.5±20.1 control (α-MEM+β-glycerophosphate and ascorbic acid)

505.1±14.3

Ti 0.3 329.6±24.0

Control

Ti + TiCaPCON 0.3 368.5±15.2 Ti 3.0 326.8±7.4 Ti + TiCaPCON 3.0 537.9±22.2* Ti 8.0 520.6±15.7*

PEET

Ti + TiCaPCON 8.0 612.6±50.6* Asterisk indicates the values that differ significantly from those of Ti controls (t-test, p<0.01). Table 3

Results of in vitro tests.

Sample

Measured characteristic Incubation time, days

Control TiCaPCON-1.2%Ag

1 9 (8-12)* 6 (6-7) 2 7 (1-8) 2 (0-4) 3 5 (2-7) 2 (0-2)

Number of L. acidophilus colonies

4 4 (2-5) 0 (0-0) L. acidophilus concentration in 1 ml, ×106

3 20.2±1.6** 10.6±2.4

Area of MC3T3-E1 cells, m2 ×103

1 1.7±0.1** 1.5±0.1

ALP activity of MC3T3-E1, nmol/mg protein/min

14 330±24** 205±15

* Median (min-max). Number of colonies was counted in 5 Petri dishes. ** Average value ±SD.

Page 20 of 20RSC Advances

RS

C A

dva

nce

s A

ccep

ted

Man

usc

rip

t

Dow

nloa

ded

by T

he U

nive

rsity

of

Mel

bour

ne L

ibra

ries

on

05 M

arch

201

3Pu

blis

hed

on 1

9 Fe

brua

ry 2

013

on h

ttp://

pubs

.rsc

.org

| do

i:10.

1039

/C3R

A23

325A

View Article Online